(Q40130622)

17 September 2017

1 reference

title

Angiotensin-converting enzyme inhibitors: medicinal chemistry and biological actions (English)

1 reference

17 September 2017

Angiotensin-converting enzyme inhibitors: Medicinal chemistry and biological actions (English)

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

17 September 2023

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

17 September 2023

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

17 September 2023

author name string

Petrillo EW Jr

1

1 reference

17 September 2017

E. W. Petrillo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6287131

17 September 2023

M. A. Ondetti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6287131

17 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6287131

17 September 2023

publication date

1 January 1982

1 reference

full work available at URL

17 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmed.2610020103

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

https://onlinelibrary.wiley.com/doi/full/10.1002/med.2610020103

17 September 2023

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Medicinal Research Reviews

17 September 2023

published in

1 reference

17 September 2017

volume

2

1 reference

17 September 2017

issue

1

1 reference

17 September 2017

page(s)

1-41

1 reference

A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610020103

New sulfhydryl compounds with potent antihypertensive activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610020103

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610020103

Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Renin-angiotensin system: biochemistry and mechanisms of action

17 September 2023

3

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Angiotensin-Converting Enzyme and the Regulation of Vasoactive Peptides

17 September 2023

5

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients

17 September 2023

11

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

17 September 2023

12

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids

17 September 2023

13

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Structure of carboxypeptidase B at 2-8 A resolution

17 September 2023

15

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Crystallographic study of the binding of dipeptide inhibitors to thermolysin: implications for the mechanism of catalysis

17 September 2023

18

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

A crystallographic study of the complex of phosphoramidon with thermolysin. A model for the presumed catalytic transition state and for the binding of extended substances

17 September 2023

19

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Binding of the by-product analog benzylsuccinic acid by carboxypeptidase A

17 September 2023

20

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Design of potent and specific inhibitors of carboxypeptidases A and B

17 September 2023

21

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

A new class of angiotensin-converting enzyme inhibitors

17 September 2023

24

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Functional residues at the active site of angiotensin converting enzyme

17 September 2023

25

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung

17 September 2023

26

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Effects of N-Mercaptoacylamino Acids on Inhibition of Angiotensin I Converting Enzyme

17 September 2023

35

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Synthesis and angiotensin-converting enzyme inhibitory activity of 3-(mercaptomethyl)-2-oxo-1-pyrrolidineacetic acids and 3-(mercaptomethyl)-2-oxo-1-piperidineacetic acids

17 September 2023

41

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Studies on inhibitory effect of phosphoramidon and its analogs on thermolysin

17 September 2023

46

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Inhibition of thermolysin and carboxypeptidase A by phosphoramidates

17 September 2023

47

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Design of potent reversible inhibitors for thermolysin. Peptides containing zinc coordinating ligands and their use in affinity chromatography

17 September 2023

48

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Inhibition of angiotensin converting enzyme with Nα-phosphoryl-L-alanyl-L-proline and Nα-phosphoryl-L-valyl-L-tryptophan

17 September 2023

49

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Metal-coordinating substrate analogs as inhibitors of metalloenzymes

17 September 2023

50

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Peptide hydroxamic acids as inhibitors of thermolysin

17 September 2023

54

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Synthesis and biological activity of a ketomethylene analog of a tripeptide inhibitor of angiotensin converting enzyme

17 September 2023

57

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

New Substrates for the Radioassay of Angiotensin Converting Enzyme of Endothelial Cells in Culture

17 September 2023

58

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Peptide-gap inhibitors: I. Competitive inhibition of aminopeptidase M by a hydrolytically resistant dipeptide analogue of glycylleucine

17 September 2023

63

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Journal of Pharmacology and Experimental Therapeutics

17 September 2023

66

204

271

Rubin

1978

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Inhibitors of angiotensin-converting enzyme for treatment of hypertension

17 September 2023

67

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Journal of Pharmacology and Experimental Therapeutics

17 September 2023

68

216

552

Gross

1981

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Effects of captopril in animal models of hypertension

17 September 2023

71

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Journal of Pharmacology and Experimental Therapeutics

17 September 2023

74

216

558

Sweet

1981

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Antihypertensive Effects of the Novel Converting-Enzyme Inhibitor YS 980 in Spontaneously Hypertensive Rats

17 September 2023

75

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme

17 September 2023

76

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

A specific orally active inhibitor of angiotensin-converting enzyme in man.

17 September 2023

77

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Use of first-dose response or plasma renin activity to predict the long-term effect of captopril: identification of triphasic pattern of blood pressure response

17 September 2023

80

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

17 September 2023

88

192

129

Heald

1977

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

Evidence for prejunctional inhibition of norepinephrine release by captopril in spontaneously hypertensive rats

17 September 2023

90

1 reference

https://api.crossref.org/works/10.1002/MED.2610020103

17 September 2023

Identifiers

1 reference

17 September 2017

1 reference